FDA expands Class II recall of blood-pressure tablets to two more lots

FDA expands Class II recall of blood-pressure tablets to two more lots

On November 3, the U. S. Food and Drug Administration classified a recall of two lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets as Class II after dissolution failures were identified, WSB-TV reported.

The recall covers the same generic blood-pressure medication previously withdrawn. The agency had earlier, on October 26, issued a Class II recall of more than 3,700 bottles of the same three-component tablets after quality testing showed they did not dissolve properly, according to USA Today and WMUR. A separate voluntary Class III recall of over 21,000 bottles of telmisartan-amlodipine tablets was announced because of potency concerns, Yahoo reported.

Actors

U.S. Food and Drug Administration Mylan Pharmaceuticals

Locations

United States

Articles

November 03, 2026
5 total
Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills
Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills

Newsday • 03 Nov 19:23

The FDA classified the recall as Class II after a quality test showed the generic Olmesartan-Amlodipine-Hydrochlorothiazide tablets failed dissolution specifications.

Credibility 92% Manip. 5% Center
FDA issues Class II recall of two lots of blood pressure tablets
FDA issues Class II recall of two lots of blood pressure tablets

WSB-TV • 03 Nov 15:43

The FDA has classified a recall of two lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets as a Class II recall after dissolution failures were identified.

Credibility 88% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WGAL • 03 Nov 10:35

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WCVB • 03 Nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WMUR • 03 Nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
November 02, 2026
2 total
Macleods Pharma USA Recalls Thousands of Blood Pressure Medication Bottles Nationwide
Macleods Pharma USA Recalls Thousands of Blood Pressure Medication Bottles Nationwide

Fox Business • 02 Nov 23:25

Macleods Pharma USA is recalling over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after the FDA found they failed dissolution testing.

Credibility 92% Manip. 8% Center
FDA issues Class II recall of thousands of generic blood pressure tablets
FDA issues Class II recall of thousands of generic blood pressure tablets

USA Today • 02 Nov 18:37

The Food and Drug Administration has classified a recall of over 3,700 bottles of generic blood-pressure medication as Class II, citing failed dissolution specifications that could reduce effectiveness.

Credibility 92% Manip. 5% Center
October 27, 2026
2 total
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills

Yahoo • 27 Oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine tablets due to potency concerns.

Credibility 78% Manip. 8% Center
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Bottles
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Bottles

EatingWell • 27 Oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine due to dosage potency issues.

Credibility 72% Manip. 8% Center